IL15 and neoplasm: Miller team incorporated a modified IL-15 cross-linker to construct a TriKE bearing scFv against CD16 on NK cells and CD33 on tumor cells (named GTB-3550), which can potently restore defective NK function and induce specific NK cell proliferation.52